UPC Analytics
ENDE
Overview · Filed: Feb 12, 2026

UPC_CoA_27/2026

NOVEL ANTITUMORAL USE OF CABAZITAXEL

AppealsMain AppealCourt of AppealAppealWritten Phase
OverviewDecisionsDocumentsTimeline
Parties

Claimants

  • Sanofi Mature IPvZentiva, k.s., Zentiva Pharma GmbH, Zentiva France

Respondents

  • —
Judges
  • Rian Kalden
  • Ingeborg Simonsson
  • Patricia Rombach
Patents
  • EP2493466
CPC codes: A61K38/193, A61K31/573, A61P35/04, A61K31/164, A61K31/56, A61P43/00, A61P13/08, A61P15/00, A61K31/337, A61P35/00, A61K45/06, A61P25/16

Sector: Pharmaceutical & Medical

Outcome
—
Filed: Feb 12, 2026
First decided: —
Language: English
Open on UPC Registry